Evaluation of pharmacokinetics and safety of valganciclovir oral suspension treatment in pediatric kidney graft recipients--preliminary report;Ocena farmakokinetyki i bezpieczeństwa stosowania walgancyklowiru w zawiesinie doustnej u dzieci po transplantacji nerki--doniesienie wstepne.

Przegla̧d lekarski

Volumn 63 Suppl 3, Issue , 2006, Pages 184-186

  Rubik, Jacek ^a   Kozłowski, Kazimierz ^a   Grenda, Ryszard ^a   Prokurat, Sylwester ^a  

^a CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; GANCICLOVIR; PRODRUG; VALGANCICLOVIR;

ARTICLE; BIOAVAILABILITY; CHILD; CLINICAL TRIAL; CYTOMEGALIC INCLUSION BODY DISEASE; HUMAN; IMMUNE DEFICIENCY; IMMUNOLOGY; KIDNEY TRANSPLANTATION; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; SUSPENSION; TRANSPLANTATION TOLERANCE;

ADMINISTRATION, ORAL; BIOLOGICAL AVAILABILITY; CHILD; CHILD, PRESCHOOL; CYTOMEGALOVIRUS INFECTIONS; GANCICLOVIR; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY TRANSPLANTATION; PRODRUGS; SUSPENSIONS; TRANSPLANTATION TOLERANCE;

EID: 39049181609     PISSN: 00332240     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)